Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
International Urogynecology Journal
|
November 22, 2013
Effect of fesoterodine on urethral closure function in women with stress urinary incontinence assessed by urethral pressure reflectometry
Niels Klarskov, Amanda Darekar, David Scholfield, et al.
The Review of Scientific Instruments
|
August 3, 2011
A new technique for the characterization of chaff elements
David Scholfield, Maung Myat, Jason Dauby, et al.
Drugs & Aging
|
February 13, 2015
Review of the efficacy and safety of fesoterodine for treating overactive bladder and urgency urinary incontinence in elderly patients
Adrian Wagg, Matthias Oelke, Javier C Angulo, et al.
Current Medical Research and Opinion
|
March 24, 2015
Fesoterodine clinical efficacy and safety for the treatment of overactive bladder in relation to patient profiles: a systematic review
Christopher Chapple, Matthias Oelke, Steven A Kaplan, et al.
Contemporary Clinical Trials
|
October 1, 2016
Development of a predictive model for urgency urinary incontinence
Amanda Darekar, Martin Carlsson, Sheila Quinn, et al.
Postgraduate Medicine
|
June 14, 2012
Evaluation of cognitive function in healthy older subjects treated with fesoterodine
Gary G Kay, Paul Maruff, David Scholfield, et al.
BJU International
|
February 21, 2014
Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial
Christopher Chapple, Tim Schneider, François Haab, et al.
The Journal of Urology
|
July 24, 2012
Investigation of a Ca2+ channel α2δ ligand for the treatment of interstitial cystitis: results of a randomized, double-blind, placebo controlled phase II trial
J Curtis Nickel, Anna Crossland, Edward Davis, et al.
Current Medical Research and Opinion
|
August 1, 2017
Characteristics of antimuscarinic responders versus suboptimal responders in a randomized clinical trial of patients with overactive bladder symptoms
Lars Grenabo, Sender Herschorn, Steven A Kaplan, et al.
Journal of Pediatric Urology
|
March 16, 2012
Dose-escalating study of the pharmacokinetics and tolerability of fesoterodine in children with overactive bladder
Bimal Malhotra, Ahmed El-Tahtawy, Ellen Q Wang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
International Urogynecology Journal
|
November 22, 2013
Effect of fesoterodine on urethral closure function in women with stress urinary incontinence assessed by urethral pressure reflectometry
Niels Klarskov, Amanda Darekar, David Scholfield, et al.
The Review of Scientific Instruments
|
August 3, 2011
A new technique for the characterization of chaff elements
David Scholfield, Maung Myat, Jason Dauby, et al.
Drugs & Aging
|
February 13, 2015
Review of the efficacy and safety of fesoterodine for treating overactive bladder and urgency urinary incontinence in elderly patients
Adrian Wagg, Matthias Oelke, Javier C Angulo, et al.
Current Medical Research and Opinion
|
March 24, 2015
Fesoterodine clinical efficacy and safety for the treatment of overactive bladder in relation to patient profiles: a systematic review
Christopher Chapple, Matthias Oelke, Steven A Kaplan, et al.
Contemporary Clinical Trials
|
October 1, 2016
Development of a predictive model for urgency urinary incontinence
Amanda Darekar, Martin Carlsson, Sheila Quinn, et al.
Postgraduate Medicine
|
June 14, 2012
Evaluation of cognitive function in healthy older subjects treated with fesoterodine
Gary G Kay, Paul Maruff, David Scholfield, et al.
BJU International
|
February 21, 2014
Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial
Christopher Chapple, Tim Schneider, François Haab, et al.
The Journal of Urology
|
July 24, 2012
Investigation of a Ca2+ channel α2δ ligand for the treatment of interstitial cystitis: results of a randomized, double-blind, placebo controlled phase II trial
J Curtis Nickel, Anna Crossland, Edward Davis, et al.
Current Medical Research and Opinion
|
August 1, 2017
Characteristics of antimuscarinic responders versus suboptimal responders in a randomized clinical trial of patients with overactive bladder symptoms
Lars Grenabo, Sender Herschorn, Steven A Kaplan, et al.
Journal of Pediatric Urology
|
March 16, 2012
Dose-escalating study of the pharmacokinetics and tolerability of fesoterodine in children with overactive bladder
Bimal Malhotra, Ahmed El-Tahtawy, Ellen Q Wang, et al.
Page
of 2